The development of NASH-induced liver cancer is influenced by other immunological responses, including resident KCs’ activation as well as leukocyte recruitment to the liver, including NK, neutrophils, monocytes, and natural killer T cells. The gene discussed is TBCE; the disease is metabolic dysfunction-associated steatohepatitis.